Launch of LIT / DRFZ Joint Group “Experimental Cell Therapy”
Transferring Research Into Practice For Patients With Rheumatic Diseases Common press release (LIT & DRFZ) The Leibniz Institute for Immunotherapy (LIT) and the German Rheumatology…
Transferring Research Into Practice For Patients With Rheumatic Diseases Common press release (LIT & DRFZ) The Leibniz Institute for Immunotherapy (LIT) and the German Rheumatology…
Statement by the German Network for Health Services Research regarding cuts to funding for the Innovation Fund On April 29, 2026, the Cabinet passed the…
Phase II study shows clinical improvement with daratumumab A team led by PD Dr. Tobias Alexander, head of the Translational Rheumatology program area at the…
Dr. Ping Shen from the Pitzer Laboratory for Osteoarthritis Research at the DRFZ has been awarded funding from the Klaus Tschira Boost Fund to research…